Medtronic Files 8K - Listing Notice

Medtronic Inc. (MDT) filed a Form 8K - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - with the U.S Securities and Exchange Commission on January 26, 2015.

Prior to the Transactions, the Medtronic Common Shares were registered pursuant to Section 12(b) of the Exchange Act and listed on the NYSE under the symbol "MDT." As a result of the Transactions, each Medtronic Common Share issued and outstanding immediately prior to the effectiveness of the Merger, other than Medtronic Common Shares held by Medtronic, was cancelled and automatically converted into the right to receive one New Medtronic ordinary share. Medtronic has requested that the NYSE file a Form 25 to withdraw the Medtronic Common Shares from listing and terminate the registration of the Medtronic Common Shares under Section 12(b) of the Exchange Act. Prior to the open of trading on the NYSE on January 27, 2015, trading in the Medtronic Common Shares will be suspended by the NYSE. Medtronic currently intends to file a Form 15 with the SEC to terminate the registration of the Medtronic Common Shares under the Exchange Act and suspend its reporting obligations under Section 15(d) of the Exchange Act in February 2015 or March 2015.

The information set forth in Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01.

The full text of this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/64670/000119312515020704/d860001d8k.htm

Any exhibits and associated documents for this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/64670/000119312515020704/0001193125-15-020704-index.htm

Public companies must file a Form 8-K, or current report, with the SEC generally within four days of any event that could materially affect a company's financial position or the value of its shares.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires